{"transactions":[{"id":1136232,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T13:38:19.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 21, 2025, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.39,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-014395","document":"form4-05232025_050515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925014395/form4-05232025_050515.xml","form_type":"4"}},{"id":1262122,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 24, 2022, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.59,"expiration_date":"2032-05-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262121,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 24, 2022, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.785,"expiration_date":"2032-05-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262120,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest in twelve equal monthly installments commencing on the grant date of May 26, 2021, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":20770},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262119,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":20770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest in twelve equal monthly installments commencing on the grant date of May 26, 2021, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20770,"derivative":{"exercise_price":0.785,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":20770},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262118,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option became fully vested on the grant date of May 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":3.53,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":20634},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262117,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":20634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option became fully vested on the grant date of May 28, 2020."}],"balance_after":20634,"derivative":{"exercise_price":0.785,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":20634},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262116,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in twelve equal monthly installments commencing on the grant date of May 19, 2020, provided, however, that the options will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.8,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262115,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in twelve equal monthly installments commencing on the grant date of May 19, 2020, provided, however, that the options will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":24000,"derivative":{"exercise_price":0.785,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262114,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve equal monthly installments commencing on the grant date of June 11, 2019, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.01,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1262113,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T19:35:54.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve equal monthly installments commencing on the grant date of June 11, 2019, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":12000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001415889-25-004757","document":"form4-02202025_120250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588925004757/form4-02202025_120250.xml","form_type":"4"}},{"id":1504521,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T18:00:23.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.43,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-014369","document":"form4-05232024_100515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000141588924014369/form4-05232024_100515.xml","form_type":"4"}},{"id":1518296,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299324010182/form4.xml","form_type":"4"}},{"id":1518295,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":2685,"price":3.96,"value":10632.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $10,625 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2685,"derivative":{"exercise_price":5.75,"exercise_date":"2024-05-10","expiration_date":"2034-05-10","underlying":"Common Stock","underlying_shares":2685},"source":{"system":"sec-edgar","filing":"0001062993-24-010182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299324010182/form4.xml","form_type":"4"}},{"id":1881685,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T17:50:22.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2023, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.65,"expiration_date":"2033-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-031706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919123031706/doc4.xml","form_type":"4"}},{"id":1894275,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:32:00.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299323011112/form4.xml","form_type":"4"}},{"id":2257406,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-25T19:50:19.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 24, 2022, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":2.59,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-031992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919122031992/doc4.xml","form_type":"4"}},{"id":2272786,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:41:49.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012386","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941871/000106299322012386/form4.xml","form_type":"4"}},{"id":2692227,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T18:16:06.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":20770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in twelve equal monthly installments commencing on the grant date of May 26, 2021, provided that the options will, in any case, be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")), through such vesting date and will vest in full upon a Change in Control (as defined in the Plan)."}],"balance_after":20770,"derivative":{"exercise_price":6.55,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":20770},"source":{"system":"sec-edgar","filing":"0001209191-21-036637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919121036637/doc4.xml","form_type":"4"}},{"id":2717468,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T16:26:44.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":28586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":28586,"derivative":{"exercise_price":2.15,"exercise_date":"2022-05-11","underlying":"Common Stock","underlying_shares":28586},"source":{"system":"sec-edgar","filing":"0000891839-21-000139","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941871/000089183921000139/edgar.xml","form_type":"4"}},{"id":3131306,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T16:30:18.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":20634,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20634,"derivative":{"exercise_price":3.53,"exercise_date":"2020-05-28","expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":20634},"source":{"system":"sec-edgar","filing":"0001209191-20-032938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919120032938/doc4.xml","form_type":"4"}},{"id":3139852,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-21T16:30:17.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in twelve equal monthly installments commencing on the grant date of May 19, 2020, provided, however, that the options will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":24000,"derivative":{"exercise_price":2.8,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-031274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919120031274/doc4.xml","form_type":"4"}},{"id":3146305,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T16:21:22.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":15679,"derivative":{"exercise_price":3.95,"exercise_date":"2021-05-14","underlying":"Common Stock","underlying_shares":15679},"source":{"system":"sec-edgar","filing":"0000891839-20-000120","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941871/000089183920000120/edgar.xml","form_type":"4"}},{"id":3491974,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T16:37:55.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve equal monthly installments commencing on the grant date of June 11, 2019, provided, however, that the option will become fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":12000,"derivative":{"exercise_price":6.01,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-036801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000120919119036801/doc4.xml","form_type":"4"}},{"id":3522414,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":79359,"kind":"person","name":"MANIAN BALA S","position":1,"cik":"0000941871","reported_name":"MANIAN BALA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T16:40:12.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":7718,"derivative":{"exercise_price":7.78,"exercise_date":"2020-05-15","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0000891839-19-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941871/000089183919000069/edgar.xml","form_type":"4"}}]}